This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bergeron, J. Articles by Alaoui-Jamali, M. A. Search for Related Content PubMed PubMed Citation Articles by Bergeron, J. Articles by Alaoui-Jamali, M. A.

Identification of the Interferon-inducible Double-Stranded RNA-dependent Protein Kinase as a Regulator of Cellular Response to Bulky Adducts¹

Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology [J. B., N. B., A. E. K., M. A. A-J.], Pharmacology and Therapeutics [M. A. A-J.], Division of Experimental Medicine [P. J. S., A. E. K., M. A. A-J.], and McGill Centre for Translational Research in Cancer [M. A. A-J.], McGill University, Montreal, Quebec, H3T 1E2 Canada

The double-stranded RNA-dependent protein kinase PKR plays a central role in IFN-mediated antiviral response. The ability of PKR mutants to transform rodent fibroblasts led to the hypothesis that PKR acts as a tumor suppressor. Recent studies have identified an expanding network of PKR signaling partners, including signal transducers and activators of transcription 1 (STAT1), p53, and IB-kinase. Here we demonstrate that PKR is involved in the cellular response to genotoxic stress. PKR-deficient mouse-embryonic fibroblasts (PKR^-/-) are hypersensitive to bulky adduct DNA damage caused by cisplatin, melphalan, and UV radiation but not to other DNA-damaging agents such as Adriamycin. PKR-deficient cells are highly susceptible to cisplatin-induced apoptosis. They demonstrate retarded cisplatin adduct removal kinetics. Most strikingly, PKR localizes to the nucleus rapidly upon cisplatin treatment. Restoration of PKR in PKR^-/- cells results in resistance to cisplatin and enhanced cell capacity to remove cisplatin DNA adducts. We conclude that PKR has a function in the regulation of cellular response to bulky adduct-inducing agents, possibly by modulating DNA repair mechanisms.

This article has been cited by other articles:

				U. von Holzen, A. Pataer, U. Raju, D. Bocangel, S. A. Vorburger, Y. Liu, X. Lu, J. A. Roth, B. B. Aggarwal, G. N. Barber, et al. The Double-Stranded RNA-Activated Protein Kinase Mediates Radiation Resistance in Mouse Embryo Fibroblasts through Nuclear Factor {kappa}B and Akt Activation Clin. Cancer Res., October 15, 2007; 13(20): 6032 - 6039. [Abstract] [Full Text] [PDF]

				A.M. Codrington, B.F. Hales, and B. Robaire Exposure of male rats to cyclophosphamide alters the chromatin structure and basic proteome in spermatozoa Hum. Reprod., May 1, 2007; 22(5): 1431 - 1442. [Abstract] [Full Text] [PDF]

				S. Li and A. E. Koromilas Dominant Negative Function by an Alternatively Spliced Form of the Interferon-inducible Protein Kinase PKR J. Biol. Chem., April 20, 2001; 276(17): 13881 - 13890. [Abstract] [Full Text] [PDF]

				L. M. Parker, I. Fierro-Monti, and M. B. Mathews Nuclear Factor 90 Is a Substrate and Regulator of the Eukaryotic Initiation Factor 2 Kinase Double-stranded RNA-activated Protein Kinase J. Biol. Chem., August 24, 2001; 276(35): 32522 - 32530. [Abstract] [Full Text] [PDF]